KR880003904A - 부정맥 치료제 - Google Patents

부정맥 치료제 Download PDF

Info

Publication number
KR880003904A
KR880003904A KR1019870010318A KR870010318A KR880003904A KR 880003904 A KR880003904 A KR 880003904A KR 1019870010318 A KR1019870010318 A KR 1019870010318A KR 870010318 A KR870010318 A KR 870010318A KR 880003904 A KR880003904 A KR 880003904A
Authority
KR
South Korea
Prior art keywords
compound
methylethyl
carbon atoms
pharmaceutically acceptable
amino
Prior art date
Application number
KR1019870010318A
Other languages
English (en)
Other versions
KR950005774B1 (ko
Inventor
쥬니어 조지 캐롤부즈바이
존 콜라츠스키 토마스
Original Assignee
아메리칸 홈 프로덕츠 코포레이션
챨스 에프. 허건
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/909,133 external-priority patent/US4721809A/en
Priority claimed from GB878710529A external-priority patent/GB8710529D0/en
Application filed by 아메리칸 홈 프로덕츠 코포레이션, 챨스 에프. 허건 filed Critical 아메리칸 홈 프로덕츠 코포레이션
Publication of KR880003904A publication Critical patent/KR880003904A/ko
Application granted granted Critical
Publication of KR950005774B1 publication Critical patent/KR950005774B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

부정맥 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 하기 일반식(I)이 화합물 또는 약제학적으로 허용되는 그의 염.
    상기식에서, R1은 탄소수 1 내지 6의 알킬설폰아미도, 탄소수 6 내지 10의 알릴설폰아미도 또는 탄소수 1 내지 6의 퍼플루오로 알킬설폰아미도이고, R2는 수소 또는 탄소수 1내지 6의 알킬이고, R3는 수소 또는 탄소수 1내지 6의 알킬이고, R4는 탄소수 1내지 6의 알킬이고, n은 정수 2,3 또는 4이다.
  2. 제1항에 있어서, R1이 CH3SO2NH-,C6H5SO2NH-또는 CF3SO2NH-이고, R2는 수소 또는 탄소수 1내지 6의 알킬이고 R3는 수소 또는 탄소수 1내지 6의 알킬이고, R4는 탄소수 1내지 6의 알킬이고, n은 정수 2,3 또는 4인 화합물 또는 약제학적으로 허용되는 그의 염.
  3. 제1항에 있어서, 다음 일반식(Ⅱ)의 화합물 또는 약제학적으로 허용되는 그의 염.
    상기식에서, R2는 수소 또는 탄소수 1내지 6의 직쇄 또는 측쇄 알킬이고, R3는 수소 또는 이소프로필이고, n은 정수 2,3 또는 4이다.
  4. 제1항에 있어서, 4-메틸설폰 아미도-N-[2-[비스(1-메틸에틸)아미노]에틸]-N-(1-메틸에틸) 벤젠설폰 아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
  5. 제1항에 있어서, 4-메틸설폰아미도-N-[2-[비스(1-메틸에틸)아미노]에틸]벤젤설폰아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
  6. 제1항에 있어서, 4-메틸설폰아미도-N-[2-[(1-메틸에틸)아미노]에틸]벤젠설폰아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
  7. 제1항에 있어서, 4-메틸설폰 아미도-N-(1-메틸에틸)-N-[2-[(1-메틸에틸)아미노]에틸] 벤젠 설폰 아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
  8. 제1항에 있어서, N-[3-[(1-메틸에틸)아미노]프로필]-4-메탄 설폰아미도 벤젠설폰 아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
  9. 제1항에 있어서, N-[2-[비스(1-메틸에틸)아미노]에틸]-N-(1-메틸에틸)-4-[(트리플루오로메틸 설포닐)아미노]벤젠설폰아미드 또는 약제학적으로 허용되는 그의 염.
  10. 제1항에 있어서, N-[2-[비스(1-메틸에틸)아미노]에틸]-4[(트리플루오로메틸설포닐)아미노]벤젠설폰 아미드인 화합물 또는 약제학적으로 허용되는 그의 염.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870010318A 1986-09-18 1987-09-17 부정맥 치료제 KR950005774B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US909133 1986-09-18
US06/909,133 US4721809A (en) 1986-09-18 1986-09-18 Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides
US8710529 1987-05-02
GB878710529A GB8710529D0 (en) 1987-05-02 1987-05-02 Benzenesulphonamides
GB8710529 1987-05-02
US909,133 1997-08-11

Publications (2)

Publication Number Publication Date
KR880003904A true KR880003904A (ko) 1988-06-01
KR950005774B1 KR950005774B1 (ko) 1995-05-30

Family

ID=26292202

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870010318A KR950005774B1 (ko) 1986-09-18 1987-09-17 부정맥 치료제

Country Status (12)

Country Link
EP (1) EP0260901B1 (ko)
KR (1) KR950005774B1 (ko)
CA (1) CA1282430C (ko)
DE (1) DE3768391D1 (ko)
DK (1) DK488687A (ko)
ES (1) ES2036577T3 (ko)
FI (1) FI874013A (ko)
GB (1) GB2195120B (ko)
GR (1) GR3001941T3 (ko)
HU (1) HU196953B (ko)
IL (1) IL83767A (ko)
PT (1) PT85691B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313918A1 (fr) * 1975-06-09 1977-01-07 Choay Sa Methoxy-2 benzenesulfonamides n-substitues, procede pour les preparer et medicaments les contenant
US4544654A (en) * 1984-03-20 1985-10-01 Schering A.G. Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof
CA1241967A (en) * 1984-05-11 1988-09-13 George C. Buzby Jr. Sulfonamides useful as anti-arrhythmic agents
US4587360A (en) * 1985-03-29 1986-05-06 American Home Products Corporation Anti-arrhythmic agents

Also Published As

Publication number Publication date
HUT45231A (en) 1988-06-28
EP0260901A1 (en) 1988-03-23
FI874013A0 (fi) 1987-09-15
FI874013A (fi) 1988-03-19
IL83767A0 (en) 1988-02-29
DK488687A (da) 1988-03-19
DK488687D0 (da) 1987-09-17
KR950005774B1 (ko) 1995-05-30
GR3001941T3 (en) 1992-11-23
GB8721522D0 (en) 1987-10-21
CA1282430C (en) 1991-04-02
HU196953B (en) 1989-02-28
ES2036577T3 (es) 1993-06-01
AU602004B2 (en) 1990-09-27
IL83767A (en) 1992-11-15
GB2195120A (en) 1988-03-30
GB2195120B (en) 1990-11-28
EP0260901B1 (en) 1991-03-06
AU7831287A (en) 1988-03-24
DE3768391D1 (de) 1991-04-11
PT85691B (pt) 1990-06-29
PT85691A (en) 1987-10-01

Similar Documents

Publication Publication Date Title
KR860000253A (ko) 벤젠설폰 아미도 유도체의 제조방법
NO892381D0 (no) 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner.
KR960705780A (ko) 평활근 이완제로서의 디아미노사이클로부텐-3.4-디온(Diaminocyclobutene-3.4-diones as smooth muscle relaxants)
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
FI946039A (fi) Substituoidut 1-okso-1,2-dihydro-isokinolinoyyli- ja 1,1-diokso-2H-1,2-bentsotiatsinoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
KR920018028A (ko) 콜레스테롤 생합성 억제제로서의 신규 아자데칼린 아미드 및 티오아미드
NO892982D0 (no) Tetrahydro-1-benz-(c,d)-indolpropionsyre-sulfonamider.
KR960007592A (ko) 신규한 피롤로카바졸
KR900003163A (ko) 시클로헥산 유도체
SE8700113L (sv) Pesticid o/w-emulsion
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR890007730A (ko) 허혈성 심질환 치료제
KR900016238A (ko) 신규 화합물
DE69423528D1 (de) Arzneimittel enthaltend Argatroban Analoga
KR900004728A (ko) 부티닐아민 유도체
KR880003904A (ko) 부정맥 치료제
KR880002822A (ko) 뇌허혈증 예방 치료제
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
KR900012896A (ko) 콜레스테롤 고혈증 치료용겸 아테롬성 동맥 경화증 치료용 신규 n-[치환 아릴]-n'-(치환 알콕시)-우레아류 및 티오우레아류
CA2180621A1 (fr) Nouveaux derives d'acide aminophenylphosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR840004081A (ko) 설포닐 우레아의 제조방법
KR880009909A (ko) 2-아미노아세트아미드 유도체
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
ATE56967T1 (de) Amidderivate.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee